Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 29, Issue 1, 2011, Pages 142-143

  Rodriguez Rodriguez L ^a   Garcia Bermudez M ^a   Gonzalez Juanatey, C ^b   Vazquez Rodriguez, T R ^b   Miranda Filloy, J A ^b   Fernandez Gutierrez, B ^c   Llorca, J ^d   Martin, J ^a   Gonzalez Gay, M A ^e  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GHRELIN RECEPTOR GENE; HAPLOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; SPAIN;

GHRELIN RECEPTOR;

ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GHRELIN; SPAIN;

EID: 79955673714     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, MARTIN J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 8-17.
2. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
3. KOJIMA M, HOSODA H, MATSUO H, KANGAWA K: Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001; 12: 118-22.
4. PAPOTTI M, GHE C, CASSONI P et al.: Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-7.
5. GONZALEZ-REY E, CHORNY A, DEL MORAL RG, VARELA N, DELGADO M: Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis 2007; 66: 582-8.
6. BAESSLER A, FISCHER M, MAYER B et al.:Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 2007; 16: 887-99.
7. GONZALEZ-GAY MA, GARCIA-UNZUETA MT, BERJA A et al.: Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1644-6.
8. ROBLEDO G, RUEDA B, GONZALEZ-GAY MA et al.: Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28: 25-9.
9. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
10. PALOMINO-MORALES R, GONZALEZ-JUANATEY C et al.: Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 964-70.
11. PALOMINO-MORALES R, GONZALEZ-JUANATEY C, VAZQUEZ-RODRIGUEZ TR et al.: Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28: 695-701.
12. PALOMINO-MORALES R, GONZALEZ-JUANATEY C, VAZQUEZ-RODRIGUEZ TR et al.: Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. Clin Exp Rheumatol 2010; 28: 68-72.